Announcements Trials
Browse Landscape

Status

Completed 4Recruiting 1

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 10Observational 4

Sponsor

Cancer Type

Genitourinary 4

Conditions

Breast Neoplasms 1387Neoplasms 1164Colorectal Neoplasms 624Lung Neoplasms 559Prostatic Neoplasms 538Carcinoma, Non-Small-Cell Lung 443Carcinoma, Hepatocellular 296Stomach Neoplasms 272Pancreatic Neoplasms 270Colonic Neoplasms 264Ovarian Neoplasms 230Head and Neck Neoplasms 228Rectal Neoplasms 221Melanoma 215Multiple Myeloma 202Uterine Cervical Neoplasms 198Lymphoma 195Leukemia 193Precursor Cell Lymphoblastic Leukemia-Lymphoma 191Neoplasm Metastasis 178Carcinoma, Renal Cell 177Esophageal Neoplasms 173Brain Neoplasms 173Leukemia, Myeloid, Acute 158Urinary Bladder Neoplasms 138Recurrence 123Polycystic Ovary Syndrome 122Liver Neoplasms 118Hematologic Neoplasms 117Endometrial Neoplasms 107

Interventions

enzalutamide 2Docetaxel 1Blood Specimen Collection 1Biopsy 1Abiraterone Acetate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Completed × Observational × Metastatic Castration Resistant Prostate Cancer × Clear all
NCT03328364 2024-11-21

A Registry Based Study Evaluating Overall Survival and Treatment Length in mCRPC Patients Treated With Enzalutamide in Sweden

Astellas Pharma Inc

Completed
211 enrolled
Genitourinary

Metastatic Castration Resistant Prostate Cancer

NCT02471469 2020-10-19

ILUMINATE

Radboud University Medical Center

Completed
40 enrolled
Genitourinary

Metastatic Castration Resistant Prostate Cancer

NCT02426333 2019-09-13

OPTIMUM

Radboud University Medical Center

Completed
56 enrolled
Genitourinary

Metastatic Castration Resistant Prostate Cancer

NCT02424448 2016-07-26

BIOMETHS

The Christie NHS Foundation Trust

Completed
6 enrolled
Genitourinary

Metastatic Castration Resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡